PRESS RELEASE published on 11/10/2025 at 17:55, 11 months 25 days ago Galenica successfully places a bond of over CHF 250 million Galenica successfully places a CHF 250 million bond, reducing short-term liabilities and securing long-term financing. Proceeds used for Labor Team Group acquisition and general corporate purposes Acquisition Financing Bond Swiss Exchange Galenica
BRIEF published on 10/23/2025 at 06:45, 1 year ago Galenica AG to continue its sustained growth in 2025 Growth Galenica Pharmacy Drugs Labor Team
PRESS RELEASE published on 10/23/2025 at 06:40, 1 year ago Galenica remains on growth track Galenica Group reports 4.7% sales growth in Q3 2025 driven by prescription drugs and dietary supplements. Acquisition of Labor Team boosts expectations for sales and EBIT1 growth Sales Growth Dietary Supplements Galenica Prescription Drugs Labor Team
BRIEF published on 10/21/2025 at 08:00, 1 year ago Galenica Unveils Innovative Pharmacy Concept to Meet Evolving Needs Customer Experience Healthcare Digital Integration Galenica AG Pharmacy Concept
PRESS RELEASE published on 10/21/2025 at 07:55, 1 year ago Galenica strengthens basic care with new pharmacy concept Galenica tests new pharmacy concept focusing on consultations and customer experience at Amavita pharmacy in Zurich's Glattzentrum. Launch aims to reshape future pharmacies Customer Experience Galenica Pharmacy Concept Consultations Amavita
BRIEF published on 09/10/2025 at 06:50, 1 year 1 month ago Galenica Enters Diagnostics with Labor Team Acquisition Acquisition Diagnostics Galenica AG Healthcare Network Labor Team
PRESS RELEASE published on 09/10/2025 at 06:45, 1 year 1 month ago Launch of Galenica Diagnostics: Acquisition of Labor Team completed Galenica completes acquisition of Labor Team, forming Galenica Diagnostics. Fourth-largest Swiss lab to operate under Galenica. Board members merge Galenica and lab expertise Acquisition Switzerland Galenica Diagnostics Labor Team
BRIEF published on 08/07/2025 at 06:50, 1 year 2 months ago Galenica AG: Half-year growth and upward revision of EBIT forecasts Adjusted EBIT Prescription Drugs Galenica Growth Health Products And Services Swiss Pharmaceutical Market
PRESS RELEASE published on 08/07/2025 at 06:45, 1 year 2 months ago Galenica demonstrates pleasing growth and improves EBIT guidance Galenica AG demonstrates pleasing growth with 5.0% increase in Group sales, raising EBIT guidance by 7%-9%. Adjusted EBIT grows by 10.9% in the first half of 2025 Growth EBIT Guidance Galenica AG Group Sales First Half 2025
BRIEF published on 07/02/2025 at 06:50, 1 year 4 months ago Galenica Acquires Labor Team to Enter Diagnostics Business Acquisition Galenica Diagnostics Healthcare Network Labor Team
Published on 11/06/2026 at 05:15, 6 hours 8 minutes ago Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 00:53, 10 hours 30 minutes ago Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 10 hours 38 minutes ago Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/06/2026 at 10:28, 55 minutes ago Tradegate BSX continues to expand its reach in the German retail investor market
Published on 11/06/2026 at 10:15, 1 hour 8 minutes ago Marco Fuchs Receives EY Entrepreneur Of The Year 2026 Award
Published on 11/06/2026 at 10:05, 1 hour 18 minutes ago Smart City Expo 2026 closes after showing the real impact of urban solutions
Published on 11/06/2026 at 09:58, 1 hour 25 minutes ago EQS-Adhoc: Uniper SE establishes dividend policy
Published on 11/06/2026 at 09:42, 1 hour 41 minutes ago Silver for the Thorium Pioneer: Emerald Horizon Takes Second Place at “Innovator of the Year” 2026
Published on 11/05/2026 at 18:21, 17 hours 2 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
Published on 11/05/2026 at 17:45, 17 hours 38 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 11/05/2026 at 17:29, 17 hours 54 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN FR0010406082
